Back to Search
MARK NEEDLE, MD
MD
Nephrology Physician
NPI: 1265765093Individual
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
60092145(NY)
Research & Publications (14)
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.
PMID 16505426·J Clin Oncol·2006
3-trial
Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer.
PMID 16301597·J Clin Oncol·2005
3-trial
Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer.
PMID 16246975·J Clin Oncol·2005
3-trial
Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapy.
PMID 15390300·Pediatr Blood Cancer·2004
3-trial
Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial.
PMID 15226328·J Clin Oncol·2004
3-trial
Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.
PMID 14993230·J Clin Oncol·2004
3-trial
Phase II trial of antiepidermal growth factor receptor antibody C225 in patients with advanced renal cell carcinoma.
PMID 12795534·Invest New Drugs·2003
3-trial
A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma.
PMID 12684400·Clin Cancer Res·2003
3-trial
A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952.
PMID 12626128·Neuro Oncol·2003
3-trial
Safety experience with IMC-C225, an anti-epidermal growth factor receptor antibody.
PMID 12422314·Semin Oncol·2002
6-review
Epidermal growth factor receptor as a therapeutic target in head and neck cancer.
PMID 12174340·Semin Radiat Oncol·2002
6-review
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study.
PMID 11877270·Blood·2002
3-trial
Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas.
PMID 10659012·J Neurosurg·2000
5-case
Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
PMID 10623688·J Clin Oncol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2231 NW 58 ST
BOCA RATON, FL 33496 - Phone
- (561) 995-8327
Quick Facts
- NPI
- 1265765093
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile